Nifty

:

11661.85

Sensex

:

39298.38

75.50 (0.65%)
246.32 (0.63%)

Login

Nifty
Sensex

:
:

11661.85
39298.38

75.50 (0.65%)
246.32 (0.63%)

Gufic Biosciences Ltd.

Pharmaceuticals & Drugs

Rating :

66/99

BSE: 509079 | NSE: GUFICBIO

Watchlist

NSE BSE

71.70

18-Oct-2019

Open
High
Low
Previous Close

72.20
73.25
71.10
72.10

Volume
Traded Value (lacs)
52 Week High
52 Week Low

13648
9.86
108.00
51.05

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

558.43
22.43
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

648.62
0.07%
6.80

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

18.78
18.28
12.63

EBITDA CAGR (%)

10 Years
5 Years
3 Years

24.40
26.37
14.91

PAT CAGR (%)

10 Years
5 Years
3 Years

33.39
39.45
34.49

P:E (Median)

8 Years
5 Years
3 Years

32.72
43.76
46.32

P:BV (Average)

8 Years
5 Years
3 Years

7.46
10.47
12.31

EV:EBITDA (Average)

8 Years
5 Years
3 Years

14.45
18.32
20.01

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Jun 19 Jun 18 Var% Mar 19 Mar 18 Var% Dec 18 Dec 17 Var% Sep 18 Sep 17 Var%
Net Sales 92.39 78.78 17.28% 91.55 78.91 16.02% 87.65 92.42 -5.16% 92.42 75.28 22.77%
Expenses 80.25 69.94 14.74% 79.03 69.90 13.06% 75.69 80.13 -5.54% 80.13 65.62 22.11%
EBITDA 12.14 8.85 37.18% 12.52 9.02 38.80% 11.96 12.30 -2.76% 12.30 9.66 27.33%
EBIDTM 13.14% 11.23% 13.68% 11.43% 13.65% 13.30% 13.30% 12.83%
Other Income 1.02 0.33 209.09% 3.29 1.48 122.30% 0.23 0.70 -67.14% 0.70 0.88 -20.45%
Interest 2.77 1.95 42.05% 3.42 2.68 27.61% 2.35 2.47 -4.86% 2.47 2.70 -8.52%
Depreciation 1.20 0.95 26.32% 1.64 1.27 29.13% 1.05 1.01 3.96% 1.01 1.00 1.00%
PBT 9.19 6.28 46.34% 10.75 6.54 64.37% 8.79 9.52 -7.67% 9.52 7.35 29.52%
Tax 2.38 2.59 -8.11% 4.73 5.49 -13.84% 2.91 3.33 -12.61% 3.33 1.79 86.03%
PAT 6.81 3.69 84.55% 6.01 1.05 472.38% 5.88 6.19 -5.01% 6.19 5.56 11.33%
PATM 7.37% 4.68% 6.57% 1.33% 6.71% 6.69% 6.69% 7.39%
EPS 0.88 0.48 83.33% 0.77 0.13 492.31% 0.76 0.79 -3.80% 0.79 0.72 9.72%

Description Jun 19 Jun 18 Var% Mar 19 Mar 18 Var% Dec 18 Dec 17 Var% Sep 18 Sep 17 Var%
Net Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Expenses 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBITDA 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Net Sales 364.01 350.77 305.58 245.52 202.20 151.55 123.01 100.14 83.57 71.47 62.73 Net Sales Growth 11.87% 14.79% 24.46% 21.42% 33.42% 23.20% 22.84% 19.83% 16.93% 13.93% Cost Of Goods Sold 184.97 161.37 128.58 107.42 90.84 73.47 55.61 46.05 40.87 32.80 32.43 Gross Profit 179.04 189.40 177.01 138.10 111.35 78.08 67.40 54.09 42.70 38.66 30.30 GP Margin 49.19% 54.00% 57.93% 56.25% 55.07% 51.52% 54.79% 54.01% 51.09% 54.09% 48.30% Total Expenditure 315.10 304.78 266.80 222.57 182.51 137.28 110.98 89.40 76.23 65.33 57.55 Power & Fuel Cost - 3.43 3.58 3.51 3.57 3.16 2.95 3.21 2.50 2.13 2.04 % Of Sales - 0.98% 1.17% 1.43% 1.77% 2.09% 2.40% 3.21% 2.99% 2.98% 3.25% Employee Cost - 46.85 44.62 41.03 31.95 19.23 12.25 5.45 4.37 3.96 3.60 % Of Sales - 13.36% 14.60% 16.71% 15.80% 12.69% 9.96% 5.44% 5.23% 5.54% 5.74% Manufacturing Exp. - 43.16 37.69 28.94 23.54 15.48 17.33 9.14 7.49 7.21 3.68 % Of Sales - 12.30% 12.33% 11.79% 11.64% 10.21% 14.09% 9.13% 8.96% 10.09% 5.87% General & Admin Exp. - 32.32 31.50 27.03 20.56 13.56 8.82 3.79 4.96 4.06 3.66 % Of Sales - 9.21% 10.31% 11.01% 10.17% 8.95% 7.17% 3.78% 5.94% 5.68% 5.83% Selling & Distn. Exp. - 11.36 13.26 9.11 8.19 8.78 12.41 19.92 15.85 14.91 11.59 % Of Sales - 3.24% 4.34% 3.71% 4.05% 5.79% 10.09% 19.89% 18.97% 20.86% 18.48% Miscellaneous Exp. - 6.29 7.57 5.53 3.85 3.61 1.61 1.84 0.18 0.27 11.59 % Of Sales - 1.79% 2.48% 2.25% 1.90% 2.38% 1.31% 1.84% 0.22% 0.38% 0.88% EBITDA 48.92 45.99 38.78 22.95 19.69 14.27 12.03 10.74 7.34 6.14 5.18 EBITDA Margin 13.44% 13.11% 12.69% 9.35% 9.74% 9.42% 9.78% 10.72% 8.78% 8.59% 8.26% Other Income 5.24 4.17 2.86 1.44 0.66 0.57 0.63 0.39 0.37 0.16 0.45 Interest 11.01 10.16 8.88 6.34 6.20 4.46 3.92 3.69 2.85 2.12 2.27 Depreciation 4.90 4.65 4.40 3.68 3.79 3.85 2.47 2.18 1.88 1.81 1.66 PBT 38.25 35.35 28.37 14.37 10.36 6.53 6.27 5.26 2.97 2.37 1.69 Tax 13.35 13.41 13.48 5.35 3.03 2.37 2.01 1.93 1.44 0.91 0.47 Tax Rate 34.90% 37.93% 44.99% 37.23% 29.25% 36.29% 32.06% 36.69% 48.48% 38.40% 27.81% PAT 24.89 21.94 16.48 9.02 7.32 4.16 4.26 3.33 1.53 1.46 1.23 PAT before Minority Interest 24.89 21.94 16.48 9.02 7.32 4.16 4.26 3.33 1.53 1.46 1.23 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 6.84% 6.25% 5.39% 3.67% 3.62% 2.74% 3.46% 3.33% 1.83% 2.04% 1.96% PAT Growth 50.94% 33.13% 82.71% 23.22% 75.96% -2.35% 27.93% 117.65% 4.79% 18.70% Unadjusted EPS 3.20 2.82 2.12 1.17 0.95 0.54 0.55 0.43 0.20 0.19 0.16

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Shareholder's Funds 75.35 54.14 37.33 33.96 27.10 26.21 22.39 19.51 18.44 17.42 Share Capital 7.78 7.78 7.74 7.74 7.74 7.74 7.74 7.74 7.74 7.74 Total Reserves 67.56 46.35 29.59 26.22 19.36 18.47 14.66 11.78 10.70 9.69 Non-Current Liabilities 17.16 12.54 9.16 14.56 16.58 24.63 23.53 8.75 9.71 19.48 Secured Loans 11.25 4.43 3.20 4.84 8.62 10.17 13.72 1.65 2.25 14.93 Unsecured Loans 0.06 3.89 3.42 2.82 2.88 4.71 4.72 2.67 3.08 2.31 Long Term Provisions 1.86 2.26 2.29 1.39 1.41 1.35 1.19 1.00 0.77 0.00 Current Liabilities 186.34 168.55 128.18 103.68 83.61 60.31 43.65 47.06 35.41 18.66 Trade Payables 77.81 75.98 43.74 52.62 49.53 31.80 20.14 22.22 14.64 13.40 Other Current Liabilities 16.28 17.24 20.75 14.10 13.01 11.28 7.74 6.42 3.48 4.10 Short Term Borrowings 84.69 69.17 46.97 32.28 17.90 14.77 13.74 15.32 13.11 0.00 Short Term Provisions 7.57 6.16 16.73 4.67 3.16 2.47 2.04 3.10 4.17 1.15 Total Liabilities 278.85 235.23 174.67 152.20 127.29 111.15 89.57 75.32 63.56 55.56 Net Block 24.45 22.85 21.96 22.15 25.11 30.23 26.83 17.71 17.32 14.88 Gross Block 37.19 31.00 25.65 51.31 50.81 48.46 42.59 31.60 29.41 25.17 Accumulated Depreciation 12.74 8.15 3.68 29.17 25.71 18.23 15.76 13.89 12.09 10.29 Non Current Assets 46.34 37.02 31.42 32.69 35.81 41.84 39.36 24.33 22.16 17.13 Capital Work in Progress 9.63 2.05 0.04 0.00 0.00 0.00 2.98 1.07 0.00 2.25 Non Current Investment 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 Long Term Loans & Adv. 10.16 8.73 7.60 9.01 9.17 11.32 7.34 5.49 4.77 0.00 Other Non Current Assets 2.09 3.38 1.82 1.52 1.52 0.28 2.20 0.05 0.06 0.00 Current Assets 232.51 198.20 143.25 119.51 91.48 69.30 50.22 50.99 41.40 38.42 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 94.28 94.20 63.02 50.26 36.80 26.12 20.00 16.91 12.77 10.36 Sundry Debtors 103.18 80.80 52.12 56.23 33.38 28.21 20.01 22.57 17.64 15.05 Cash & Bank 7.59 7.50 5.64 6.16 6.21 2.54 1.28 0.96 0.95 1.08 Other Current Assets 27.46 0.38 1.09 0.76 15.08 12.44 8.93 10.55 10.05 11.94 Short Term Loans & Adv. 26.36 15.33 21.38 6.10 12.45 9.60 7.19 10.22 9.79 11.89 Net Current Assets 46.17 29.66 15.07 15.84 7.87 8.99 6.57 3.93 5.99 19.77 Total Assets 278.85 235.22 174.67 152.20 127.29 111.14 89.58 75.32 63.56 55.55

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Cash From Operating Activity 5.21 -4.82 -4.13 -4.32 11.15 10.87 5.26 5.16 1.04 3.84 PBT 35.35 29.95 14.37 11.19 6.53 6.27 5.26 2.97 2.37 1.69 Adjustment 13.35 12.07 9.75 8.84 8.19 6.27 5.95 4.86 3.84 4.01 Changes in Working Capital -33.52 -30.40 -23.70 -21.31 -1.60 -0.19 -4.42 -1.87 -4.45 -1.07 Cash after chg. in Working capital 15.18 11.63 0.42 -1.28 13.12 12.36 6.79 5.97 1.76 4.63 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -9.98 -16.44 -4.55 -2.65 -1.96 -1.49 -1.54 -0.80 -0.72 -0.80 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 -0.38 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -12.99 -8.84 -4.69 -0.51 -2.39 -2.78 -13.26 -3.33 -2.03 -2.96 Net Fixed Assets -13.77 -7.36 25.62 -0.50 -2.35 -2.89 -12.90 -3.26 -1.99 -2.87 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others 0.78 -1.48 -30.31 -0.01 -0.04 0.11 -0.36 -0.07 -0.04 -0.09 Cash from Financing Activity 7.71 14.40 7.41 4.78 -5.09 -6.82 8.32 -1.82 0.86 -0.28 Net Cash Inflow / Outflow -0.08 0.75 -1.41 -0.05 3.67 1.26 0.32 0.02 -0.13 0.59 Opening Cash & Equivalents 3.74 2.99 4.28 6.21 2.54 1.28 0.96 0.95 1.08 0.49 Closing Cash & Equivalent 3.66 3.74 2.87 6.16 6.21 2.54 1.28 0.96 0.95 1.08

Financial Ratios

Standalone

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Book Value (Rs.) 9.68 6.96 4.83 4.39 3.50 3.39 2.90 2.52 2.38 2.25 ROA 8.54% 8.04% 5.52% 5.24% 3.49% 4.25% 4.04% 2.20% 2.46% 2.38% ROE 33.89% 36.03% 25.31% 23.99% 15.60% 17.55% 15.89% 8.05% 8.17% 7.21% ROCE 29.65% 34.10% 24.26% 24.24% 18.38% 17.45% 18.44% 15.02% 12.43% 11.98% Fixed Asset Turnover 10.57 11.21 6.77 4.19 3.22 2.86 2.85 2.83 2.71 2.58 Receivable days 93.16 76.39 75.93 76.38 70.29 67.55 73.52 84.97 80.78 77.68 Inventory Days 95.44 90.36 79.39 74.21 71.80 64.60 63.71 62.71 57.14 60.04 Payable days 115.32 80.93 87.99 110.87 119.47 95.34 87.64 91.90 77.66 72.55 Cash Conversion Cycle 73.27 85.82 67.32 39.73 22.62 36.81 49.59 55.78 60.27 65.17 Total Debt/Equity 1.30 1.47 1.52 1.26 1.21 1.27 1.55 1.05 1.04 0.99 Interest Cover 4.48 4.37 3.27 2.67 2.46 2.60 2.43 2.04 2.12 1.75

Top Investors:

sbi healthcare opportunities fund

mrs. vipula jayesh choksi

icici prudential healthcare and diagnostics (p.h.d.)fund

mr. jagdish n. master

sbi active select fund

Annual Reports:

News Update:

Gufic Biosciences - Quarterly Results
13th Aug 2019, 23:46 PM

Read More
Gufic Biosciences to launch Botulinum Neurotoxin
19th Jul 2019, 08:56 AM

The company has received regulatory approval to manufacture and market Botulinum Neurotoxin
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback